![Curt Herberts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Curt Herberts
Geschäftsführer bei
Senti Sub I, Inc.
Profil
Curt A. Herberts is currently an Advisor at Bioverge Funds Management LLC and Chief Operating Officer at Senti Sub I, Inc. Formerly, Mr. Herberts was Chief Business Officer & Senior Vice President at Sangamo Therapeutics, Inc. from 2016 to 2018, Chief Operating Officer at Senti Biosciences, Inc. from 2021 to 2022, and President & Chief Operating Officer at Kriya Therapeutics, Inc. from 2022 to 2025.
Education includes an undergraduate degree from Stanford University conferred in 2003 and graduate studies at Keck Graduate Institute of Applied Life Sciences.
Aktive Positionen von Curt Herberts
| Unternehmen | Position | Beginn |
|---|---|---|
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Geschäftsführer | 01.01.2021 |
Bioverge Funds Management LLC
 Bioverge Funds Management LLC Investment ManagersFinance Bioverge Funds Management invests in companies located in the United States. The firm targets companies operating across a broad range of sectors. It provides financing for seed and early stage capital requirements. | Berater | - |
Ehemalige bekannte Positionen von Curt Herberts
| Unternehmen | Position | Ende |
|---|---|---|
Kriya Therapeutics, Inc.
 Kriya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing gene therapies for treatment of chronic diseases | Präsident | 01.09.2025 |
Senti Biosciences, Inc.
 Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Finanzdirektor/CFO | 01.01.2021 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 26.05.2018 |
Ausbildung von Curt Herberts
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Keck Graduate Institute of Applied Life Sciences
 Keck Graduate Institute of Applied Life Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bioverge Funds Management LLC
Bioverge Funds Management LLC Investment ManagersFinance Bioverge Funds Management invests in companies located in the United States. The firm targets companies operating across a broad range of sectors. It provides financing for seed and early stage capital requirements. | Finance |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Health Technology |
Kriya Therapeutics, Inc.
Kriya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company developing gene therapies for treatment of chronic diseases | Health Technology |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Health Technology |
